Sign Up | Log In | What is SocialPicks?

Ceradyne Inc (CRDN) Trade Now » Rate CRDN - Discuss CRDN - Add to Watch List

Sector: Capital Goods > Industry: Aerospace & Defense

SocialPicks Sentiment:

** v.s. other stocks

This Quarter's Sentiment:

All:

90.0%

Top:

100.0%

Rate CRDN:

Home

Analysis & Videos

Quotes

Bull or Bear

Discuss

CRDN Analysis & Videos »

... View All >

CRDN: Bull or Bear?

Ceradyne Inc CRDN

62%

-59.26%
in 503 days

BUY: Ceradyne
(nasdaq: CRDN)
Ceradyne Inc., a manufacturer of technical
ceramics for a wide range of military and
industrial uses, has seen its shares fall 28% year
to date and 60% from its peak in July 2007.
After record sales and earnings in 2007, the
lumpy nature of military orders resulted in a
volatile backlog and a 20% reduction in the
earnings guidance range for 2008.
However, we remain bullish on the longterm
demand trends for the company's
advanced armor products as well as emerging
industrial products in alternative energy and
other are...

Continue reading »

By Marian Filo (-24.55% risk: aggressive) 07/19/08

1 comment

Ceradyne: Why the Low Valuation? CRDN

-54.81%
in 533 days

Ceradyne (CRDN) develops, manufactures and markets advanced technical ceramic products and components for defense, industrial, automotive/diesel and commercial applications. It is a large supplier of ceramic body armor plates used to protect soldiers. It also makes high purity ceramic crucibles used in the manufacture of polycrystalline silicon for photovoltaic solar cells. This is definitely a growth area, but the market hasn’t tagged CRDN as an alternate energy stock as yet.

Next earnings report due: July

Continue reading »

By Ranjit Thomas (+27.76% risk: moderate) 06/19/08

Comment

Bullish on CRDN ... CRDN

36%

-25.21%
in 127 days
(closed on 04/01/08)

Continue reading »

By Vogell (-7.23% risk: aggressive) 11/26/07

Comment

Catching The Falling Knife That Is Ceradyne CRDN

7 %

-58.20%
in 744 days

Ceradyne ( crdn ) has been in free fall since reporting earnings on October 30, 2007. It has fell from it's peak of $84.41 and is trading today at only $42.42! Wall street was not impressed when Ceradyne guided to the low end of guidance and has been punishing this stock ever since. This company is trading at only a 7.99 P/E ratio which is basically saying that this company can't continue to grow it's bottom line.

Let me give you some basic information about Ceradyne for all of you who are not familiar with this company. It is a small company valued at just over a billi...

Continue reading »

By 1greenthumb (-35.87% risk: aggressive) 11/21/07

Comment

GOOD PRICE!!!! PREPARE TO AVERAGE DOWN IF NEEDED CRDN

4 %

-58.04%
in 745 days

Five years from now you will be very happy you bought this so cheap.

Continue reading »

By Thomas C (-20.38% risk: aggressive) 11/20/07

1 comment

... View All >

People Bullish on CRDN

schadenfreud

Analyst

N/A

3 mos ago

nickem

Analyst

N/A

4 mos ago

seismicstock

Principal

70%

7 mos ago

supratrader

Principal

N/A

7 mos ago

william0509

Associate

67%

7 mos ago

People Bearish on CRDN

dilmuns

Sr. Analyst

39%

about 1 year ago

... View All >

ROCK-STAR INVESTORS

Rank	Name	Sharpe Ratio	Avg Return	Followers
1	noshoes	21.10	+34.44%	381
2	Gerald Greene	18.14	+71.24%	211
3	stockmarketfunding.com	17.66	+25.60%	55
4	akiralegrand	13.47	+14.32%	62
5	anup2104	12.13	+74.22%	40

... more »

POPULAR STOCKS

Symbol	Company Name	Sentiment
MA	MasterCard Inc
SIRI	Sirius Satellite Radio Inc
IBM	International Business Machines Corp
BIDU	Baiducom Inc ADS
AMZN	Amazoncom Inc
SBUX	Starbucks Corp

... more »

TODAY'S HEADLINES

LDK Solar's Growth Potential Offset by Gross Margin Pressure
by Paul Cheung (Zacks.com) about LDK

Cisco Systems Still a Wait and See
by Thomas Catino (Ant & Sons) about CSCO

The Merrill Lynch Diet: Starving Shareholders
by Zack Miller (BloggingStocks) about MER

Until Housing Improves, Don't Expect Stocks to Rebound
by J.D. Steinhilber (Agile Investing) about SPY

Google Blows Q2: Multiple Compression to Continue
by Henry Blodget about GOOG

... more »

TODAY'S TOP PICKS

DNDN		Cancer Vaccines: Investing Opportunities beyond Dendreon (NASDAQ: D... by Mike Havrilla
CLDA		BioMed Research Reports: Clinical Data (NASDAQ: CLDA), Lpath (OTC: ... by Mike Havrilla
PARD		Biotech Stocks - Beware of The Covered Call Trap by Ivan Mutaftchiev
PBIO		Under the Radar Healthcare Stocks: Protox, Pressure BioSciences, Un... by Mike Havrilla
ISIS		ISIS - Last Tuesday's Drop Presents a Nice Buy Opportunity by Ivan Mutaftchiev

... more »

StreetInsider.com on CRDN

Wells Fargo Upgrades Ceradyne (CRDN) to Market Perform; XSAPI Thesis Confirmed

Ceradyne (CRDN) Reports Q3 EPS of $0.26; Guides FY10

Form 8-K CERADYNE INC For: Oct 27

Ceradyne, Inc. Reports Third Quarter, Nine-Month 2009 Financial Results

Trading Radar for 10/27: Visa (V), Baidu.com (BIDU), WYNN Resorts (WYNN), RF Micro (RFMD), BP (BP) Report

Discussion Wall

+ Add

Be the first to start a discussion and earn 2 points.

... more »

More Resources

About Ceradyne Inc - Answers.com

Historical Prices - Yahoo

Message Boards - BoardCentral.com

More Info: Yahoo | Google | Reuters

IN THE PRESS

None of the information contained on SocialPicks.com constitutes a recommendation by SocialPicks or its users that any particular security, portfolio of securities, transaction, or investment strategy is suitable for any specific person. SocialPicks is not responsible for the posts, discussions, and recommendations of the users on the Site. SocialPicks does not provide investment advice. You must make your own independent decisions regarding any security, portfolio of securities, transaction, or investment strategy mentioned on the website. SocialPicks' users' past results are not necessarily indicative of future performance. Neither SocialPicks nor any of its users guarantees any specific outcome or profit, and you should be aware of the real risk of loss in following any strategy or investments discussed on the website. You understand and agree that you use the Site and Services at your own discretion and risk and that you will be solely responsible for any damages that arise from such use. Before acting on any information contained on the website, you should consider whether it is suitable for your particular circumstances and strongly consider seeking advice from your own financial or investment adviser.